N-acetylcysteine efficacy in patients hospitalized with COVID-19 pneumonia: a systematic review and meta-analysis
Background: N-acetylcysteine (NAC) is a mucolytic agents with anti-inflammatory properties that has been suggested as an adjunctive therapy in patients with COVID-19 pneumonia. Objectives: We conducted a systematic review and meta-analysis to evaluate available evidence on the possible beneficial ef...
Main Authors: | Paraskevas Themistoklis, Kantanis Anastasios, Karalis Iosif, Michailides Christos, Karamouzos Vasileios, Koniari Ioanna, Pierrakos Charalampos, Velissaris Dimitrios |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2023-03-01
|
Series: | Romanian Journal of Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.2478/rjim-2023-0001 |
Similar Items
-
A Literature Review of Pathophysiology, Clinical Manifestations, Medications and Optimal Dosage, Outpatient, and Post-hospitalization Use of Anticoagulation in COVID-19 Patients
by: Dimitrios Velissaris, et al.
Published: (2023-04-01) -
Impact of Bacterial Infections on COVID-19 Patients: Is Timing Important?
by: Christos Michailides, et al.
Published: (2023-02-01) -
External validation of the 4C Mortality Score and PRIEST COVID-19 Clinical Severity Score in patients hospitalized with COVID-19 pneumonia in Greece
by: Paraskevas Themistoklis, et al.
Published: (2022-12-01) -
Evaluation of Reliability and Validity of the RALE and BRIXIA Chest-X Ray Scores in Patients Hospitalized with COVID-19 Pneumonia
by: Paraskevas Themistoklis, et al.
Published: (2023-09-01) -
N-Acetylcysteine, N-Acetylcysteine Amide, and Thioredoxin Mimetic Peptides Regenerate Mercaptoalbumin and Exhibit Antioxidant Activity
by: Sonia Eligini, et al.
Published: (2024-03-01)